5.9k Share this

CVS Health (NYSE: CVS) is scheduled to report its Q1 2022 results on Wednesday, May 4. We expect CVS stock to trade sideways post the results announcement, with Q1 revenue and earnings likely being in-line with the consensus estimates. The overall economic growth likely bolstered the revenue growth in Q1. CVS should benefit from testing demand due to the spread of Omicron in Q1. That said, the company expects a 70% to 80% y-o-y cut in Covid-19 vaccine volume and a 40% to 50% decline in at-store diagnostic testing volume for the full-year 2022. While we expect CVS to report an in-line Q1, we find that CVS stock is currently undervalued, as discussed below. Our interactive dashboard analysis on CVS Health’s Earnings Preview has additional details.

(1) Revenues expected to align with the consensus estimates

  • Trefis estimates CVS’ Q1 2022 revenues to be around $75.5 billion, compared to the $75.4 billion consensus estimate.
  • While CVS’ Covid-19 vaccine and testing drove its revenue growth in 2021, their contribution is expected to be much lower this year.
  • Q1 2022 marked the spread of Omicron and a rise in Covid-19 cases in the U.S., implying that CVS’ revenue from testing likely remained high.
  • With economic growth and opening up of economies, CVS is likely to see an increase in footfall at its stores, aiding its retail sales growth.
  • Looking back at Q4 2021, CVS reported a 10% y-o-y rise in sales to $76.6 billion led by higher retail and pharmacy services revenue.
  • Our dashboard on CVS Health’s Revenues offers more details on the company’s top line and its comparison to peers.

(2) EPS likely to be marginally above the consensus estimates

  • CVS’ Q1 2022 adjusted earnings per share is expected to be $2.20 per Trefis analysis, slightly ahead of the $2.15 consensus estimate.
  • CVS’ adjusted net income of $2.6 billion in Q4 2021 reflected a 54% y-o-y rise, primarily due to higher revenues and operating margin expansion.
  • On an adjusted basis, CVS operating margins expanded over 100 bps to 5.4% in Q4. Our dashboard on CVS Health’s Operating Income has more details.
  • For the full-year 2022, we expect the adjusted EPS to be $8.40 aligning with the level seen in 2021.

(3) CVS stock is undervalued

  • We estimate CVS Health’s Valuation to be $116, which is 21% above the current market price of $96.
  • This represents a P/EBITDA multiple of 7.5x based on our CVS Health EBITDA forecast.
  • That said, if the company reports upbeat Q1 results and 2022 guidance better than the street estimates, the P/EBITDA multiple will likely be revised upward, resulting in higher levels for CVS stock.


While CVS stock looks like it is undervalued, it is helpful to see how CVS Health’s Peers fare on metrics that matter. You will find other valuable comparisons for companies across industries at Peer Comparisons.

Furthermore, the Covid-19 crisis has created many pricing discontinuities which can offer attractive trading opportunities. For example, you’ll be surprised how counter-intuitive the stock valuation is for Walmart vs. VMware VMW .

What if you’re looking for a more balanced portfolio instead? Our high-quality portfolio and multi-strategy portfolio have beaten the market consistently since the end of 2016.

Invest with Trefis Market Beating Portfolios

See all Trefis Price Estimates

Source: Forbes

5.9k Share this
You May Also Like

Joe Biden’s Last Sit-Down Press Interview Was 100 Days Ago

Friday not only marks President Joe Biden’s lowest approval rating — he has…

Everything, Everywhere’ Passes $50 Million, Becomes A24’s Top Grosser

Everything Everywhere All At Once A24 With another $889,738 on Friday, a…

Dave Chappelle Attacker Charged with Attempted Murder in Alleged December Stabbing

The armed assailant who was arrested earlier is this month after storming…

Islamic Mufti Sentences Man to Death for Murder of Priest

A criminal court in Alexandria, Egypt, sentenced a man to death on Wednesday…

NBA and Owners Have More than $10 Billion Invested in Red China

Not only does the NBA and its various owners have more than…

Ex world boxing champion Glenn McCrory is charged ‘after calling two teenage waitresses ‘pet’

Ex world boxing champion Glenn McCrory is charged with using threatening and…

Tesla stock is down almost 45% since January

Tesla’s share price fell yet further on Friday to close 6.42 percent down,…

Advanced Micro Devices Stock Has Jumped More Than 5x Since Late 2018: Here’s Why

CHINA – 2022/05/14: In this photo illustration, an AMD logo is displayed…